HYDROMET SUMMARY
HYDROCODONE BITARTRATE AND
This product contains hydrocodone (dihydrocodeinone) bitartrate, a semisynthetic centrally acting narcotic antitussive. Homatropine methylbromide is included in a subtherapeutic amount to discourage deliberate overdosage. Each 5 mL (one teaspoonful) contains:
Hydrocodone Bitartrate........................ 5 mg
Homatropine Methylbromide............... 1 . 5 mg
Hydromet (hydrocodone/homatropine) is indicated for the following:
For the symptomatic relief of cough.
|
NEWS HIGHLIGHTSMedia Articles Related to Hydromet (Hydrocodone / Homatropine)
Whooping Cough Immunity Lasts 30 Years or More
Source: MedicineNet Pertussis Specialty [2009.11.02]
Title: Whooping Cough Immunity Lasts 30 Years or More
Category: Health News
Created: 10/30/2009 12:10:00 PM
Last Editorial Review: 11/2/2009
Whooping Cough (Pertussis)
Source: MedicineNet Tetanus Specialty [2009.08.26]
Title: Whooping Cough (Pertussis)
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 8/26/2009
Unvaccinated Kids Getting Whooping Cough
Source: MedicineNet Pertussis Specialty [2009.05.26]
Title: Unvaccinated Kids Getting Whooping Cough
Category: Health News
Created: 5/26/2009
Last Editorial Review: 5/26/2009
Cover Your Cough!
Source: MedicineNet Severe Acute Respiratory Syndrome (SARS) Specialty [2008.10.07]
Title: Cover Your Cough!
Category: Health Fact Tool
Created: 11/15/2004
Last Editorial Review: 10/7/2008
Chronic Cough
Source: MedicineNet Alpha 1 Antitrypsin Deficiency Specialty [2007.12.07]
Title: Chronic Cough
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/7/2007
Published Studies Related to Hydromet (Hydrocodone / Homatropine)
Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. [2003.01]
RATIONALE: The subjective, psychomotor, and physiological effects of prescription compounds containing the opioid hydrocodone have not been studied in a population of non-drug-abusing people who might be prescribed these compounds for cough or pain relief. OBJECTIVES: To characterize the effects of a hydrocodone combination product, Hycodan, which contains hydrocodone and a peripherally-acting anticholinergic, homatropine, in non-drug-abusing volunteers... CONCLUSIONS: Hycodan at the highest dose tested had effects similar to that of a prototypic mu agonist, morphine. Both drugs produced pleasant (including drug liking) as well as unpleasant subjective effects. Post-session ratings of overall liking and "want to take drug again" were not significant.
Clinical Trials Related to Hydromet (Hydrocodone / Homatropine)
A Study Comparing VicodinŽ CR and NORCOŽ to Placebo in Subjects With Acute Pain Following Bunionectomy [Completed]
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety
of the administration of Extended Release Hydrocodone/Acetaminophen and Immediate Release
Hydrocodone/Acetaminophen with placebo over a 12 hour dosing period in patients who have had
a bunionectomy, and to assess the safety of the drug for 7 days after patients are discharged
from the hospital.
A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (VicodinŽ CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery [Completed]
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety
of the administration of 2 different dose levels of Extended Release
Hydrocodone/Acetaminophen with placebo over a 48 hour dosing period in patients who have had
bunionectomy surgery, and to assess the safety of the drug for 7 days after patients are
discharged from the hospital.
A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (VicodinŽ CR)and Placebo in Subjects With Osteoarthritis [Completed]
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety
of the administration of Extended Release Hydrocodone/Acetaminophen with placebo over a
5-week dosing period in patients with osteoarthritis.
A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CRŽ) in Subjects With Acute Pain Following Bunionectomy [Completed]
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety
of the administration of Extended-Release Hydrocodone/Acetaminophen compared to placebo over
a 48 hour dosing period in patients who have had bunionectomy surgery and to assess the
safety of the drug for 7 days after patients are discharged from the hospital.
A Study of the Efficacy and Safety of Tramadol HCl/Acetaminophen, Hydrocodone Bitartrate/Acetaminophen and Placebo in Patients With Pain From an Ankle Sprain With a Partial Torn Ligament [Completed]
The purpose of this study is to explore the pain-relieving effects and safety of two
analgesic treatment regimens as compared to placebo in patients experiencing acute
musculoskeletal pain. Patients who are experiencing at least moderate acute musculoskeletal
pain from an ankle sprain severe enough to require prescription pain relief medication will
be randomized to receive either tramadol HCl/acetaminophen, hydrocodone
bitartrate/acetaminophen or placebo.
|
